CB
Collplant Biotechnologies Ltd
🇺🇸XNAS.CLGNUnited StatesHealthcare
$3.42USDdown -0.07 (-2.01%)ClosedEnd of day10:39 PM
Price$3.42-0.07 (-2.01%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- IL0004960188
- CUSIP
- 19516R107
Company
- Employees
- 39
- Headquarters
- Rehovot, United States
- Website
- https://collplant.com
- CEO
- Mr. Yehiel Tal
Market
- Shares outstanding
- 1.9M
- Market cap
- $6.47M
Highlights
- Market cap
- $6.47M
- EPS LTM
- -$9.55
- P/E LTM
- -0.06
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $389K-84.26%down year on year
- Net income
- -$13.13M+5.28%up year on year
- Gross margin
- -319.28%-4,007.23%down year on year
- Free cash flow
- -$11.6M+6.56%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.